Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.760315
Title: The contribution of discoidin domain receptor 1 to the pathogenesis of diffuse large B cell lymphoma
Author: Margielewska, Sandra Karolina
ISNI:       0000 0004 7432 3056
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Collagen is the ligand for the discoidin domain receptor-1 (DDR1), a receptor tyrosine kinase that is over-expressed in Hodgkin lymphoma. However, the role of DDR1 in diffuse large B cell lymphoma (DLBCL) is not known. I showed that DDR1 is over-expressed in a subset of DLBCL where it positively correlates with expression of its collagen ligands, and negatively correlates with expression of mitotic spindle genes. DDR1 correlated genes also overlapped with three aneuploidy signatures and DDR1 expression correlated significantly with autosomal aneuploidy index. RNAseq analysis revealed that over-expression of DDR1 in primary germinal centre B cells down-regulated expression of CENPE, an essential component of the mitotic spindle checkpoint that when inactivated leads to chromosome mis-segregation and aneuploidy. CENPE expression was also significantly reduced in primary DLBCL. Moreover, I showed that the constitutive activation of DDR1 in an in vitro lymphoma model led to aneuploidy. Finally, I showed that DDR1 can be inhibited by three small molecules and established the basis for in vivo model to test these inhibitors in DLBCL xenograft. My data provide evidence that DDR1 can induce aneuploidy in B cells, and as such identify a mechanism to potentially explain the link between chronic inflammation and lymphomagenesis.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.760315  DOI: Not available
Keywords: RB Pathology ; RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Share: